Specificity of arecoline and apomorphine and the site of action of arecoline in inhibiting the diurnal prolactin surge.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D001115:Arecoline / Q000494:pharmacology*; D001286:Atropine Derivatives / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D002369:Castration; D002940:Circadian Rhythm / Q000187:drug effects*; D004958:Estradiol / Q000031:analogs & derivatives / Q000494:pharmacology; D005260:Female; D006801:Humans; D008464:Mecamylamine / Q000494:pharmacology; D011388:Prolactin / Q000097:blood*; D051381:Rats; D011976:Receptors, Muscarinic / Q000187:drug effects; D011978:Receptors, Nicotinic / Q000187:drug effects; D013239:Stereotyped Behavior / Q000187:drug effects; D013997:Time Factors
D001286:Atropine Derivatives; D011976:Receptors, Muscarinic; D011978:Receptors, Nicotinic; D001115:Arecoline; D004958:Estradiol; D008464:Mecamylamine; D011388:Prolactin; D001058:Apomorphine